優莎娜 USNA 深 滬
等待開盤 03-26 09:30:00 美东时间
17.19
+0.180
+1.06%
華盛通- 最 高17.40
- 今 開17.20
- 成交量 10.45万股
- 最 低 16.975
- 昨 收 17.01
- 總市值 3.14亿
- 52周最高 38.32
- 市盈率 靜 29.67
- 換手率 0.57%
- 52周最低 16.715
- 委 比 -33.33%
- 總股本 1828.09万
- 歷史最高 137.95
- 量 比 0.71
- 振 幅 2.50%
- 歷史最低 11.55
- 每 手 1
- 風險率 5.02%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多USANA's CellSentials Supplement Earns Independent Quality Seal
USANA (NYSE:USNA), a global leader in cellular nutrition, today announced that its flagship CellSentials supplement has earned the prestigious ConsumerLab.com Seal of Approval. This highly respected third-party
03-24 19:18
Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments
Issued on behalf of Doseology Sciences Inc. Equity-Insider.com VANCOUVER, BC, March 5, 2026 /PRNewswire/ -- Consumers are voting with their wallets, and zero-sugar is winning. Zero-sugar be...
03-05 22:00
USANA CEO Kevin Guest Urges Leaders to Read for Competitive Advantage
USANA CEO Kevin Guest Urges Leaders to Read for Competitive Advantage USANA Health Sciences Chairman and CEO Kevin Guest urged business leaders to treat disciplined reading as a competitive advantage during National Reading Month, saying it strengthens thinking, communication, decision-making, and r
03-02 20:27
Protein Pop Launches Protein Pop Plus at Costco Nationwide
The brand expands its Protein Pop line with a carbonated, clear protein beverage delivering 30 grams of protein per can SALT LAKE CITY, Feb. 25, 2026 /PRNewswire/ -- Rise Wellness announced ...
02-25 20:07
USANA Chief Legal Officer Joshua Foukas Disposes of Common Shares
USANA Chief Legal Officer Joshua Foukas Disposes of Common Shares Joshua Foukas, Chief Legal Officer of USANA Health Sciences Inc., reported a disposal of the company’s common shares. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologi
02-24 08:12
USANA Health Sciences reports Q4 net sales rise
USANA Health Sciences reports Q4 net sales rise Overview Nutritional supplements maker's fiscal Q4 net sales rose 6% yr/yr Adjusted diluted EPS for fiscal Q4 fell 6% yr/yr Company anticipates flat to 8% growth in fiscal 2026 net sales Outlook USANA projects fiscal 2026 consolidated net sales between
02-18 05:24
Usana Health Sciences Q4 Earnings Assessment
Usana Health Sciences (NYSE:USNA) just disclosed its Q4 earnings on Tuesday, Fe...
02-18 05:18
BRIEF-USANA Health Sciences Q4 EPS USD -0.1
BRIEF-USANA Health Sciences Q4 EPS USD -0.1 Feb 17 (Reuters) - USANA Health Sciences outlook FY sales USD 140-155 million. outlook FY EPS USD 1.11-1.45
02-18 05:15
Earnings Scheduled For February 17, 2026
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likel...
02-17 19:11
Format Innovation Reshapes a $438B Functional Market
ISSUED ON BEHALF OF DOSEOLOGY SCIENCES INC. VANCOUVER, BC, Feb. 13, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – The global functional food and beverage market is projected to rea...
02-13 23:50
